# LatchBio

> LatchBio is a San Francisco company building an AI-native data platform for biology. It lets scientists store, analyze, and visualize data from 40+ lab kits and instruments without writing code or managing cloud infrastructure - turning raw sequencing and experimental output into reproducible, publication-ready results. Founded in 2021 by three Berkeley dropouts, it now serves thousands of scientists at biopharmas and research labs and is positioning itself as 'the AI agent for biology data analysis.'

- **Founded:** 2021
- **Headquarters:** San Francisco, United States
- **Founders:** Alfredo Andere (Co-Founder & CEO), Kenny Workman (Co-Founder & CTO), Kyle Giffin (Co-Founder & COO)
- **Team size:** ~30 employees
- **Products:** Workflows, Pods, Plots, Registry, File Storage
- **Notable:** Emerged from stealth in 2021 with a $5M seed round led by Lux Capital., Raised a $28M Series A co-led by Coatue and Lux Capital in 2022., Reported total funding of approximately $163M across multiple rounds.

## Products & services

- **Workflows** — Orchestration of bioinformatics pipelines at scale, built on Nextflow, including pre-built solutions for bulk RNA-Seq, ATAC-Seq, qPCR, gene editing and spatial transcriptomics.
- **Pods** — Scalable cloud compute for reproducible, interactive analyses without provisioning servers.
- **Plots** — An interactive visualization builder for exploring and presenting biological data.
- **Registry** — Structured capture of experimental metadata to keep results organized and FAIR-compliant.
- **File Storage** — Centralized data management connecting data from 40+ kits and instruments.
- **AI Agent / Pre-built Solutions** — An AI assistant and library of ready-to-run analyses positioning Latch as 'the AI agent for biology data analysis,' plus white-labeled portals for kit and instrument makers.

## Achievements

- Emerged from stealth in 2021 with a $5M seed round led by Lux Capital.
- Raised a $28M Series A co-led by Coatue and Lux Capital in 2022.
- Reported total funding of approximately $163M across multiple rounds.
- Grew to a reported 4,000+ scientists and 300+ biopharmas and R&D labs.
- Built code-free analysis for 40+ kits and instruments, claiming ~80% cost reduction versus traditional methods.

## Latest updates

- **2026-04** — Reported Series B financing (approximately $130M) bringing total funding to roughly $163M.
- **2022-06** — Raised $28M Series A co-led by Coatue and Lux Capital to bring a modern data analysis stack to biologists.
- **2021-10** — Emerged from stealth with a $5M seed round led by Lux Capital.

## Links

- Website: https://latch.bio
- LinkedIn: https://www.linkedin.com/company/latchbio
- Twitter/X: https://twitter.com/latchbio
- GitHub: https://github.com/latchbio

---

Profile page: https://yespress.io/latchbio
Published by YesPress — https://yespress.io
Last updated: 2026-06-14